Alterity Therapeutics (PRNAD) Total Debt (2011 - 2015)

Alterity Therapeutics (PRNAD) posted quarterly Total Debt of $424.62 for Q4 2015, up 4451.55% on a QoQ basis from $9.33 in Q2 2015.

Alterity Therapeutics (PRNAD) Total Debt (2011 - 2015) Analysis & Trends

Alterity Therapeutics (PRNAD) has reported Total Debt for 4 consecutive years, with $424.62 the latest figure, recorded in Q4 2015.

  • In Q4 2015, Total Debt changed N/A year-over-year to $424.62; the TTM figure through Dec 2015 stood at $424.62 (changed N/A YoY), while the FY2015 annual figure was $9.33, changed N/A from the prior year.
  • Total Debt came in at $424.62 for Q4 2015 at Alterity Therapeutics, up from $9.33 in the prior quarter.
  • The five-year high for Total Debt was $865088.8 in Q2 2013, with the low at $9.33 in Q2 2015.
  • Average Total Debt over 4 years is $386122.0, with a median of $339441.3 recorded in 2012.
  • Across the five-year window, Total Debt declined 10.14% in 2012 and soared 154.86% in 2013, its largest moves.
  • Year by year, Total Debt stood at $336559.4 in 2011, then surged by 132.82% to $783567.3 in 2012, then climbed by 10.4% to $865088.8 in 2013, then tumbled by 99.95% to $424.62 in 2015.
  • According to Business Quant data, Total Debt over the past three periods registered $424.62, $9.33, and $865088.8 for Q4 2015, Q2 2015, and Q2 2013 respectively.

Peer Comparison

Historic Data

Download Data
DateValue
Dec 31, 2015 424.62
Jun 30, 2015 9.33
Jun 30, 2013 865,088.82
Dec 31, 2012 783,567.34
Jun 30, 2012 339,441.30
Dec 31, 2011 336,559.41
Jun 30, 2011 377,763.00